Literature DB >> 29169876

EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation.

Robert Pirker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29169876     DOI： 10.1016/S1470-2045(17)30873-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?

Authors:  Elisabeth Quoix; Virginie Westeel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives.

Authors:  Andreas Tiefenbacher; Robert Pirker
Journal:  Memo       Date:  2018-05-18

3.  Prediction of VEGF and EGFR Expression in Peripheral Lung Cancer Based on the Radiomics Model of Spectral CT Enhanced Images.

Authors:  Linhua Wu; Jian Li; Xiaowei Ruan; Jialiang Ren; Xuejun Ping; Bing Chen
Journal:  Int J Gen Med       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.